TEST BANK v
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
v v v v v v v
Author: Teri Moser Woo and Wendy L. Wright
v v v v v v v
, TABLE OF CONTENT v v
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ..................................................................... 4
v v v v v v v v v v
Chapter 2. Review of Basic Principles of Pharmacology...................................................................................... 5
v v v v v v v
Chapter 3. Rational Drug Selection..................................................................................................................... 11
v v v v
Chapter 4. Legal and Professional Issues in Prescribing ..................................................................................... 14
v v v v v v v
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
v v v v
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................. 19
v v v v v
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
v v v v
Chapter 8. Herbal Therapies ................................................................................................................................ 28
v v v
Chapter 9. Cannabis ............................................................................................................................................ 31
v v
Chapter 10. Pharmacoeconomics ........................................................................................................................ 35
v v
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................... 38
v v v v v v v
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................. 45
v v v v v v v
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................. 53
v v v v v v v v
Chapter 14. Drugs Affecting the Respiratory System ......................................................................................... 61
v v v v v v
Chapter 15. Drugs Affecting the Hematological System .................................................................................... 65
v v v v v v
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
v v v v v v v v v
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
v v v v v v v
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................. 77
v v v v v v
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ................... 80
v v v v v v v v v v v
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................ 83
v v v v v v v v v v v
Chapter 21. Drugs Affecting the Reproductive System ...................................................................................... 86
v v v v v v
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................. 92
v v v v v v v
Chapter 23. Drugs Affecting the Integumentary System .................................................................................... 96
v v v v v v
Chapter 24. Drugs Used to Treat Bacterial Infections ...................................................................................... 101
v v v v v v v
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ....................................................... 105
v v v v v v v v v v
Chapter 26. Drugs Used to Treat Inflammatory Processes ............................................................................... 108
v v v v v v v
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................. 111
v v v v v v v v v
Chapter 28. Anemia .......................................................................................................................................... 113
v v
Chapter 29. Anxiety and Depression................................................................................................................. 116
v v v v
Chapter 30. Attention Deficit-Hyperactivity Disorder ...................................................................................... 120
v v v v
Chapter 31. Asthma and Allergy ....................................................................................................................... 122
v v v v
Chapter 32. Chronic Obstructive Pulmonary Disease ....................................................................................... 125
v v v v v
Chapter 33. Contraception ................................................................................................................................. 127
v v
Chapter 34. COVID-19: Acute and Chronic ..................................................................................................... 130
v v v v v
Chapter 35. Dermatological Conditions ............................................................................................................ 134
v v v
Chapter 36. Diabetes Management ................................................................................................................... 138
v v v
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ...................................................................... 146
v v v v v v v
Chapter 38. Headaches ...................................................................................................................................... 149
v v
Chapter 39. Heart Failure .................................................................................................................................. 153
v v v
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................ 158
v v v v v v v
Chapter 41. Menopausal Hormone Therapy ..................................................................................................... 161
v v v v
,Chapter 42. Hyperlipidemia .............................................................................................................................. 164
v v
Chapter 43. Hypertension .................................................................................................................................. 169
v v
Chapter 44. Hyperthyroidism and Hypothyroidism .......................................................................................... 174
v v v v
Chapter 45. Obesity ........................................................................................................................................... 177
v v
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................. 181
v v v v v v v
Chapter 47. Pneumonia ..................................................................................................................................... 185
v v
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................ 187
v v v v v v
Chapter 49. Substance Use Disorders ............................................................................................................... 190
v v v v
Chapter 50. Tuberculosis ................................................................................................................................... 195
v v
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa .......... 197
v v v v v v v v v v v v
Chapter 52. Urinary Tract Infections ................................................................................................................ 200
v v v v
Chapter 53. Women as Patients......................................................................................................................... 203
v v v v
Chapter 54. Men as Patients .............................................................................................................................. 207
v v v v
Chapter 55. Pediatric Patients ........................................................................................................................... 209
v v v
Chapter 57. Geriatric Patients ........................................................................................................................... 213
v v v
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e v v v v Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
v v v v v v v v v v
MULTIPLE CHOICE v
1. Nurse practitioner prescriptive authority is regulated by:
v v v v v v
A. The National Council of State Boards of Nursing
v v v v v v v
B. The U.S. Drug Enforcement Administration
v v v v
C. The State Board of Nursing for each state
v v v v v v v
D. The State Board of Pharmacy
v v v v
ANS: C v PTS: v v 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber
v v v v v v v v v v v v v
vinclude:
A. Nurses know more about pharmacology than other prescribers because they take it
v v v v v v v v v v v
both in their basic nursing program and in their APRN program.
v v v v v v v v v v v
B. Nurses care for the patient from a holistic approach and include the patient in
v v v v v v v v v v v v v
decision-making regarding their care.
v v v v
C. APRNs are less likely to prescribe narcotics and other controlled substances.
v v v v v v v v v v
D. APRNs are able to prescribe independently in all states, whereas a physician’s
v v v v v v v v v v v
assistant needs to have a physician supervising their practice.
v v v v v v v v v
ANS: B v PTS: v v 1
3. Clinical judgment in prescribing includes:
v v v v
A. Factoring in the cost to the patient of the medication prescribed
v v v v v v v v v v
B. Always prescribing the newest medication available for the disease process
v v v v v v v v v
C. Handing out drug samples to poor patients v v v v v v
D. Prescribing all generic medications to cut costs v v v v v v
ANS: A v PTS: v v 1
4. The process for choosing an effective drug for a disorder includes:
v v v v v v v v v v
A. Asking the patient what drug they think would work best for them
v v v v v v v v v v v
B. Consulting nationally recognized guidelines for disease management
v v v v v v
C. Prescribing medications that are available as samples before writing a prescription
v v v v v v v v v v
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
v v v v v v v
ANS: B v PTS: v v 1
5. Nonintentional nonadherence of drug therapy may occur due to: v v v v v v v v
A. Belief that medication does not work
v v v v v
B. Adverse drug reactions v v
C. Chronic conditions that require daily therapy
v v v v v
D. Forgetfulness or distraction v v
ANS: D v PTS: v v 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
v v v v v v v
Author: Teri Moser Woo and Wendy L. Wright
v v v v v v v
, TABLE OF CONTENT v v
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ..................................................................... 4
v v v v v v v v v v
Chapter 2. Review of Basic Principles of Pharmacology...................................................................................... 5
v v v v v v v
Chapter 3. Rational Drug Selection..................................................................................................................... 11
v v v v
Chapter 4. Legal and Professional Issues in Prescribing ..................................................................................... 14
v v v v v v v
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
v v v v
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................. 19
v v v v v
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
v v v v
Chapter 8. Herbal Therapies ................................................................................................................................ 28
v v v
Chapter 9. Cannabis ............................................................................................................................................ 31
v v
Chapter 10. Pharmacoeconomics ........................................................................................................................ 35
v v
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................... 38
v v v v v v v
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................. 45
v v v v v v v
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................. 53
v v v v v v v v
Chapter 14. Drugs Affecting the Respiratory System ......................................................................................... 61
v v v v v v
Chapter 15. Drugs Affecting the Hematological System .................................................................................... 65
v v v v v v
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
v v v v v v v v v
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
v v v v v v v
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................. 77
v v v v v v
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ................... 80
v v v v v v v v v v v
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................ 83
v v v v v v v v v v v
Chapter 21. Drugs Affecting the Reproductive System ...................................................................................... 86
v v v v v v
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................. 92
v v v v v v v
Chapter 23. Drugs Affecting the Integumentary System .................................................................................... 96
v v v v v v
Chapter 24. Drugs Used to Treat Bacterial Infections ...................................................................................... 101
v v v v v v v
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ....................................................... 105
v v v v v v v v v v
Chapter 26. Drugs Used to Treat Inflammatory Processes ............................................................................... 108
v v v v v v v
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .................................................................................. 111
v v v v v v v v v
Chapter 28. Anemia .......................................................................................................................................... 113
v v
Chapter 29. Anxiety and Depression................................................................................................................. 116
v v v v
Chapter 30. Attention Deficit-Hyperactivity Disorder ...................................................................................... 120
v v v v
Chapter 31. Asthma and Allergy ....................................................................................................................... 122
v v v v
Chapter 32. Chronic Obstructive Pulmonary Disease ....................................................................................... 125
v v v v v
Chapter 33. Contraception ................................................................................................................................. 127
v v
Chapter 34. COVID-19: Acute and Chronic ..................................................................................................... 130
v v v v v
Chapter 35. Dermatological Conditions ............................................................................................................ 134
v v v
Chapter 36. Diabetes Management ................................................................................................................... 138
v v v
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ...................................................................... 146
v v v v v v v
Chapter 38. Headaches ...................................................................................................................................... 149
v v
Chapter 39. Heart Failure .................................................................................................................................. 153
v v v
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................ 158
v v v v v v v
Chapter 41. Menopausal Hormone Therapy ..................................................................................................... 161
v v v v
,Chapter 42. Hyperlipidemia .............................................................................................................................. 164
v v
Chapter 43. Hypertension .................................................................................................................................. 169
v v
Chapter 44. Hyperthyroidism and Hypothyroidism .......................................................................................... 174
v v v v
Chapter 45. Obesity ........................................................................................................................................... 177
v v
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................. 181
v v v v v v v
Chapter 47. Pneumonia ..................................................................................................................................... 185
v v
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................ 187
v v v v v v
Chapter 49. Substance Use Disorders ............................................................................................................... 190
v v v v
Chapter 50. Tuberculosis ................................................................................................................................... 195
v v
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa .......... 197
v v v v v v v v v v v v
Chapter 52. Urinary Tract Infections ................................................................................................................ 200
v v v v
Chapter 53. Women as Patients......................................................................................................................... 203
v v v v
Chapter 54. Men as Patients .............................................................................................................................. 207
v v v v
Chapter 55. Pediatric Patients ........................................................................................................................... 209
v v v
Chapter 57. Geriatric Patients ........................................................................................................................... 213
v v v
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6e v v v v Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
v v v v v v v v v v
MULTIPLE CHOICE v
1. Nurse practitioner prescriptive authority is regulated by:
v v v v v v
A. The National Council of State Boards of Nursing
v v v v v v v
B. The U.S. Drug Enforcement Administration
v v v v
C. The State Board of Nursing for each state
v v v v v v v
D. The State Board of Pharmacy
v v v v
ANS: C v PTS: v v 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber
v v v v v v v v v v v v v
vinclude:
A. Nurses know more about pharmacology than other prescribers because they take it
v v v v v v v v v v v
both in their basic nursing program and in their APRN program.
v v v v v v v v v v v
B. Nurses care for the patient from a holistic approach and include the patient in
v v v v v v v v v v v v v
decision-making regarding their care.
v v v v
C. APRNs are less likely to prescribe narcotics and other controlled substances.
v v v v v v v v v v
D. APRNs are able to prescribe independently in all states, whereas a physician’s
v v v v v v v v v v v
assistant needs to have a physician supervising their practice.
v v v v v v v v v
ANS: B v PTS: v v 1
3. Clinical judgment in prescribing includes:
v v v v
A. Factoring in the cost to the patient of the medication prescribed
v v v v v v v v v v
B. Always prescribing the newest medication available for the disease process
v v v v v v v v v
C. Handing out drug samples to poor patients v v v v v v
D. Prescribing all generic medications to cut costs v v v v v v
ANS: A v PTS: v v 1
4. The process for choosing an effective drug for a disorder includes:
v v v v v v v v v v
A. Asking the patient what drug they think would work best for them
v v v v v v v v v v v
B. Consulting nationally recognized guidelines for disease management
v v v v v v
C. Prescribing medications that are available as samples before writing a prescription
v v v v v v v v v v
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
v v v v v v v
ANS: B v PTS: v v 1
5. Nonintentional nonadherence of drug therapy may occur due to: v v v v v v v v
A. Belief that medication does not work
v v v v v
B. Adverse drug reactions v v
C. Chronic conditions that require daily therapy
v v v v v
D. Forgetfulness or distraction v v
ANS: D v PTS: v v 1
